List view / Grid view
Strike NGS workflow gold with our broad portfolio of automation solutions, delivering reliable, high-throughput results. But don't take our word for it! Hear from our customer.
Strike NGS workflow gold with our broad portfolio of automation solutions, delivering reliable, high-throughput results. But don't take our word for it! Hear from our customer.
Check out our library of NGS-related webinars from global researchers and industry professionals to explore possibilities with our Biomek automated workstations and Echo acoustic liquid handlers.
Generate accurate data by automating your NGS workflows with Beckman Coulter Life Sciences’ flexible automated liquid handling solutions that deliver reliable results.
Explore how to apply our acoustic and tip-based liquid handling solutions for your NGS workflows in metagenomics, sample QC, RNASeq, microbiome, SARS-CoV 2 to name a few.
Automation solutions from Beckman Coulter Life Sciences alleviate your library prep pain points, whether you need automation for a few samples or a high-throughput solution.
Work with one trusted partner for instruments, software, consumables and service to help keep your laboratory running smoothly. Smooth processes save time, money and maximise your lab’s ROI.
Scientists have published a report on the whole genome sequences of 150 thousand participants in the UK biobank.
Droplet Digital PCR (ddPCR) offers greater accuracy and precision in quantifying viral titer in gene therapies.
Researchers have developed a two-step approach using whole exome sequencing to focus on genes and pathways that predict whether cancer patients will respond to immunotherapy.
A recent whole genome sequencing study has revealed hidden insights into the causes of cancer. In an exclusive article, Dr Andrea Degasperi from the Early Cancer Institute at the University of Cambridge, UK spoke to Drug Target Review's Ria Kakkad about the study's implications and the future of whole genome sequencing.
This infographic will explore Mycoplasma contamination in cell cultures and the best technologies for detection.
Podcast discussion featuring CAR-T Cell therapy development and reviewing current challenges and future potentials for these cell therapies.
Hear from leading industry experts in this emerging field who discuss: challenges related to antigen and adjuvant selection, vaccine design, immune response improvement and future treatment options.
9 May 2022 | By PerkinElmer and C4
Looking for a way to address the undruggable proteins in the human body? Watch this free on-demand webinar where industry experts discuss strategies to accelerate TPD drug discovery efforts using high-throughput cell-based assays.
